231 related articles for article (PubMed ID: 11072382)
1. [Schistosomiasis: diagnosis and treatment].
Ripert C
Presse Med; 2000 Sep; 29(28):1583-5. PubMed ID: 11072382
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of 700 cases of bilharziasis with the new drugs oxamniquine, oltipraz, praziquantel].
Lapierre J; Keita A; Faurant C; Heyer F; Tourte-Schaefer C; Ancelle T; Dupouy-Camet J
Bull Soc Pathol Exot Filiales; 1983 Nov; 76(5):526-33. PubMed ID: 6673843
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of oxamniquine and praziquantel in the treatment of Schistosoma mansoni infection: a controlled trial.
Ferrari ML; Coelho PM; Antunes CM; Tavares CA; da Cunha AS
Bull World Health Organ; 2003; 81(3):190-6. PubMed ID: 12764515
[TBL] [Abstract][Full Text] [Related]
4. Schistosomiasis: Drugs used and treatment strategies.
Siqueira LDP; Fontes DAF; Aguilera CSB; Timóteo TRR; Ângelos MA; Silva LCPBB; de Melo CG; Rolim LA; da Silva RMF; Neto PJR
Acta Trop; 2017 Dec; 176():179-187. PubMed ID: 28803725
[TBL] [Abstract][Full Text] [Related]
5. Replacing oxamniquine by praziquantel against Schistosoma mansoni infection in a rural community from the sugar-cane zone of Northeast Brazil: an epidemiological follow-up.
Beck L; Favre TC; Pieri OS; Zani LC; Domas GG; Barbosa CS
Mem Inst Oswaldo Cruz; 2001; 96 Suppl():165-7. PubMed ID: 11586444
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis for hycanthone drug action in schistosome parasites.
Guzman M; Rugel A; Tarpley RS; Cao X; McHardy SF; LoVerde PT; Taylor AB
Mol Biochem Parasitol; 2020 Mar; 236():111257. PubMed ID: 32027942
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of schistosomiasis mansoni].
de Carvalho SA
Rev Paul Med; 1982; 99(2):26-8. PubMed ID: 7156674
[No Abstract] [Full Text] [Related]
8. Current results in the clinical therapy of schistosomiasis mansoni.
Katz N
Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):8-17, 123-33. PubMed ID: 7006041
[No Abstract] [Full Text] [Related]
9. Impact of schistosomiasis on patient and graft outcome after renal transplantation: 10 years' follow-up.
Mahmoud KM; Sobh MA; El-Agroudy AE; Mostafa FE; Baz ME; Shokeir AA; Ghoneim MA
Nephrol Dial Transplant; 2001 Nov; 16(11):2214-21. PubMed ID: 11682670
[TBL] [Abstract][Full Text] [Related]
10. Schistosomiasis.
Gryseels B
Infect Dis Clin North Am; 2012 Jun; 26(2):383-97. PubMed ID: 22632645
[TBL] [Abstract][Full Text] [Related]
11. Interventions for treating schistosomiasis mansoni.
Saconato H; Atallah A
Cochrane Database Syst Rev; 2000; (2):CD000528. PubMed ID: 10796552
[TBL] [Abstract][Full Text] [Related]
12. [Drug therapy of mansoni schistosomiasis].
Zeitune JM; Ramos SR; Sugmyama LC; Côrte AA
Arq Gastroenterol; 1980; 17(2):88-95. PubMed ID: 7213141
[TBL] [Abstract][Full Text] [Related]
13. Randomized comparative trials of single doses of the newer antischistosomal drugs at Mwanza, Tanzania. I. Praziquantel and oxamniquine for the treatment of schistosomiasis mansoni.
Rugemalila JB; Asila J; Chimbe A
J Trop Med Hyg; 1984 Dec; 87(6):231-5. PubMed ID: 6398833
[TBL] [Abstract][Full Text] [Related]
14. Praziquantel--its use, cost and possible development of resistance.
Kusel J; Hagan P
Parasitol Today; 1999 Sep; 15(9):352-4. PubMed ID: 10461159
[No Abstract] [Full Text] [Related]
15. Schistosomiasis drug therapy and treatment considerations.
Shekhar KC
Drugs; 1991 Sep; 42(3):379-405. PubMed ID: 1720380
[TBL] [Abstract][Full Text] [Related]
16. Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns.
Webster BL; Diaw OT; Seye MM; Faye DS; Stothard JR; Sousa-Figueiredo JC; Rollinson D
Acta Trop; 2013 Nov; 128(2):292-302. PubMed ID: 23022016
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of oltipraz versus praziquantel for treatment of schistosomiasis with intestinal manifestation in the Gabon (Schistosoma intercalatum and S. haematobium).
Kern P; Burchard GD; Dietrich M
Tropenmed Parasitol; 1984 Jun; 35(2):95-9. PubMed ID: 6464192
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological and immunological effects of praziquantel against Schistosoma japonicum: a scoping review of experimental studies.
Xiao SH; Sun J; Chen MG
Infect Dis Poverty; 2018 Feb; 7(1):9. PubMed ID: 29409536
[TBL] [Abstract][Full Text] [Related]
19. Further clinical trials with oxamniquine (UK 4271), a new anti-schistosomal agent.
da Silva LC; Sette H; Chamone DA; Sáez-Alquezar A; Punskas JA; Raia S
Rev Inst Med Trop Sao Paulo; 1975; 17(5):307-11. PubMed ID: 1198006
[No Abstract] [Full Text] [Related]
20. Factors affecting the acquisition of resistance against Schistosoma mansoni in the mouse. V. Reduction in the degree of resistance to reinfection after chemotherapeutic elimination of recently patent primary infections.
Doenhoff M; Bickle Q; Bain J; Webbe G; Nelson G
J Helminthol; 1980 Mar; 54(1):7-16. PubMed ID: 7373025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
